中文 | English
Return
Total: 741 , 1/75
Show Home Prev Next End page: GO
Author:( Meng TANG)

1.The efficacy and safety of caspofungin in the treatment of patients with acute exacerbation of chronic obstructive pulmonary disease and pulmonary fungal infections

Youlin ZHANG ; Meng TANG

Chinese Journal of Primary Medicine and Pharmacy 2016;23(5):730-733

2.Research advance in neurotoxicity of quantum dots

Tianshu WU ; Meng TANG

Chinese Journal of Pharmacology and Toxicology 2014;(5):794-800

4.Cognitive attitude of medical students towards standardized resident training in Shanghai in a university

Jingyan WANG ; Meng TANG ; Tong JIN

Chinese Journal of Medical Education Research 2012;(11):1183-1185

5.Ressearch on Risk Factors of Adverse Reactions Caused by Tacrolomus in Renal Transplant Recipients

Meng OUYANG ; Huawen XIN ; Xia TANG

China Pharmacist 2016;19(5):892-895

6.Association of Gene Polymorphism with Individualized Tacrolimus Dosage Regimen in Renal Transplant Recipients

Huawen XIN ; Meng OUYANG ; Xia TANG

Herald of Medicine 2016;35(8):877-881

7.Monitoring the immune state in patients with posttraumatic sepsis and clinical study on immunoregulatory effect of combined use of ulinastatin and thymosin ?_1

Lei SU ; Fansu MENG ; Youqing TANG

Medical Journal of Chinese People's Liberation Army 2001;0(11):-

8.Determination of blood boron by inductively coupled plasma atomic emission spectrometry and investigation of boron level in children's blood

Meng LI ; Yuhua YANG ; Yinxiu TANG

Journal of Xi'an Jiaotong University(Medical Sciences) 2003;0(06):-

9.QSAR method and its application to toxicity prediction of metal nanomaterials

Jiali YLNG ; Ting ZHANG ; Meng TANG

Chinese Journal of Pharmacology and Toxicology 2014;(6):947-951

10.Methodologies for evaluating hospital quality in America

Xiaoyan YAN ; Hong MENG ; Mingxin TANG

Chinese Journal of Hospital Administration 1996;0(04):-

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 741 , 1/75 Show Home Prev Next End page: GO